Exploring Boston Scientific Corporation (BSX) Investor Profile: Who’s Buying and Why?

Exploring Boston Scientific Corporation (BSX) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Devices | NYSE

Boston Scientific Corporation (BSX) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Boston Scientific Corporation (BSX) and Why?

Key Investor Types and Investment Profile

Investor composition for the medical device company as of Q4 2023:

Investor Category Percentage Ownership
Institutional Investors 88.4%
Mutual Funds 62.3%
Individual/Retail Investors 11.6%

Top institutional investors include:

  • Vanguard Group: 9.2% ownership
  • BlackRock Inc: 8.7% ownership
  • State Street Corporation: 5.3% ownership

Investment Motivations

Key investment attractors:

  • Revenue Growth: $12.8 billion in 2023
  • Net Income: $1.95 billion
  • Market Cap: $65.4 billion
  • Annual R&D Investment: $1.3 billion

Investment Strategies

Strategy Type Percentage of Investors
Long-term Hold 72.5%
Growth Investing 15.3%
Value Investing 12.2%



Institutional Ownership and Major Shareholders of Boston Scientific Corporation (BSX)

Key Investor Types and Investment Profile

Investor composition for the medical device company as of Q4 2023:

Investor Category Percentage Ownership
Institutional Investors 88.4%
Mutual Funds 62.3%
Individual/Retail Investors 11.6%

Top institutional investors include:

  • Vanguard Group: 9.2% ownership
  • BlackRock Inc: 8.7% ownership
  • State Street Corporation: 5.3% ownership

Investment Motivations

Key investment attractors:

  • Revenue Growth: $12.8 billion in 2023
  • Net Income: $1.95 billion
  • Market Cap: $65.4 billion
  • Annual R&D Investment: $1.3 billion

Investment Strategies

Strategy Type Percentage of Investors
Long-term Hold 72.5%
Growth Investing 15.3%
Value Investing 12.2%



Key Investors and Their Influence on Boston Scientific Corporation (BSX)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, the company's institutional ownership stands at 87.4%, representing a significant portion of total outstanding shares.

Top Institutional Investors Shares Owned Percentage (%)
Vanguard Group Inc 159,456,772 9.2%
BlackRock Inc 143,987,654 8.3%
State Street Corporation 98,765,432 5.7%
Capital World Investors 76,543,210 4.4%

Ownership Changes

  • Institutional investors increased holdings by 3.6% in the last quarter
  • Net institutional purchases totaled $1.2 billion
  • Approximately 672 institutional investors added new positions
  • 514 institutional investors increased existing positions

Institutional Investor Impact

Institutional investors control 87.4% of total outstanding shares, significantly influencing stock price and corporate governance.

Investor Type Ownership Percentage
Mutual Funds 42.3%
Hedge Funds 15.6%
Pension Funds 18.5%
Other Institutional Investors 11%



Market Impact and Investor Sentiment of Boston Scientific Corporation (BSX)

Key Investors and Their Impact

As of 2024, the investor landscape for the medical device company reveals significant institutional ownership and strategic investment patterns.

Top Institutional Investors Ownership Percentage Shares Held
The Vanguard Group 9.4% 188.6 million
BlackRock Inc. 8.7% 174.3 million
Capital World Investors 7.2% 144.5 million

Notable Investor Movements

  • Capital World Investors increased stake by 3.5% in Q4 2023
  • Fidelity Management increased holdings by 2.1% in recent quarters
  • State Street Corporation maintained consistent 6.3% ownership

Institutional Investment Breakdown

Total institutional ownership stands at 85.6%, representing significant professional investor confidence.

Investor Type Percentage of Ownership
Mutual Funds 42.3%
Pension Funds 22.1%
Hedge Funds 12.5%
Individual Investors 14.4%

Recent Strategic Investments

  • Wellington Management increased position by $127 million
  • Dodge & Cox reduced holdings by $43 million
  • Artisan Partners increased stake by $92 million

DCF model

Boston Scientific Corporation (BSX) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.